All Stories

  1. Teaching an old dog new tricks: A new tool for protein tyrosine phosphatase substrate discovery
  2. SH2 Domain-Containing Phosphatase-SHP2 Attenuates Fibrotic Responses through Negative Regulation of Mitochondrial Metabolism in Lung Fibroblasts
  3. Hepatocyte-specific miR-33 deletion attenuates NAFLD-NASH-HCC progression
  4. Mitogen-Activated Protein Kinase Phosphatases: No Longer Undruggable?
  5. Abstract 2374: MAP Kinase Phosphatases as Nodal Signal Regulators in Health and Disease
  6. Defining the structure-activity relationship for a novel class of allosteric MKP5 inhibitors
  7. Abstract 225: Lack Of Map Kinase Phosphatase-5 In Macrophages Protects Ldlr-null Mice Against Atherogenesis
  8. The seventh international RASopathies symposium: Pathways to a cure—expanding knowledge, enhancing research, and therapeutic discovery
  9. An Assessment of the Therapeutic Landscape for the Treatment of Heart Disease in the RASopathies
  10. MAP Kinase Phosphatase-5 Deficiency Protects Against Pressure Overload-Induced Cardiac Fibrosis
  11. Low-dose Dasatinib Ameliorates Hypertrophic Cardiomyopathy in Noonan Syndrome with Multiple Lentigines
  12. An allosteric site on MKP5 reveals a strategy for small-molecule inhibition
  13. Tyrosyl phosphorylation of PZR promotes hypertrophic cardiomyopathy in PTPN11-associated Noonan syndrome with multiple lentigines
  14. The sixth international RASopathies symposium: Precision medicine—From promise to practice
  15. O-GlcNAc transferase suppresses necroptosis and liver fibrosis
  16. Role of dual-specificity protein phosphatase DUSP10/MKP-5 in pulmonary fibrosis
  17. SH2 domain-containing Phosphatase-(SHP)-2 blunts fibrotic responses through regulation of fibroblast mitochondrial metabolism and autophagy
  18. O-GlcNAc transferase suppresses necroptosis and liver fibrosis
  19. Role of Mitogen activated-kinase (MAPK)-phosphatase (MKP)-5 in pulmonary fibrosis
  20. MKP-5 inhibition blunts fibrotic responses in-vitro and in-vivo through negative regulation of TGFB1-induced smad3-signalling
  21. Noonan Syndrome-Associated SHP2 Dephosphorylates GluN2B to Regulate NMDA Receptor Function
  22. DUSPs, twists and turns in the Journey to Vascular Inflammation
  23. Skeletal Muscle–Specific Deletion of MKP-1 Reveals a p38 MAPK/JNK/Akt Signaling Node That Regulates Obesity-Induced Insulin Resistance
  24. Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism
  25. Loss of MKP-5 promotes myofiber survival by activating STAT3/Bcl-2 signaling during regenerative myogenesis
  26. Calcium-dependent O-GlcNAc signaling drives liver autophagy in adaptation to starvation
  27. MKP-5 Establishes Skeletal Muscle Metabolic Quiescence by Negatively Regulating MAPK-dependent Mitochondrial Function
  28. A Phosphoproteomic Screen Identifies a Guanine Nucleotide Exchange Factor for Rab3A Protein as a Mitogen-activated Protein (MAP) Kinase Phosphatase-5-regulated MAP Kinase Target in Interleukin 6 (IL-6) Secretion and Myogenesis
  29. SH2 Domain–Containing Phosphatase-2 Is a Novel Antifibrotic Regulator in Pulmonary Fibrosis
  30. Low-dose dasatinib rescues cardiac function in Noonan syndrome
  31. Hepatic inositol 1,4,5 trisphosphate receptor type 1 mediates fatty liver
  32. SH2 domain-containing phosphatase-SHP-2 is a novel anti-fibrotic regulator in pulmonary fibrosis
  33. Mining the function of protein tyrosine phosphatases in health and disease
  34. Inositol 1,4,5-trisphosphate receptor type II (InsP3R-II) is reduced in obese mice, but metabolic homeostasis is preserved in mice lacking InsP3R-II
  35. Hepatic Mitogen-Activated Protein Kinase Phosphatase 1 Selectively Regulates Glucose Metabolism and Energy Homeostasis
  36. Identification of Receptor Protein Tyrosine Phosphatases (RPTPs) as Regulators of Receptor Tyrosine Kinases (RTKs) Using an RPTP siRNA-RTK Substrate Screen
  37. PZR Coordinates Shp2 Noonan and LEOPARD Syndrome Signaling in Zebrafish and Mice
  38. The Imprinted H19 LncRNA Antagonizes Let-7 MicroRNAs
  39. Improved regenerative myogenesis and muscular dystrophy in mice lacking Mkp5
  40. Receptor Protein Tyrosine Phosphatase-Receptor Tyrosine Kinase Substrate Screen Identifies EphA2 as a Target for LAR in Cell Migration
  41. Novel Role for SHP-2 in Nutrient-Responsive Control of S6 Kinase 1 Signaling
  42. The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of β-catenin phosphorylation
  43. O-GlcNAc Transferase/Host Cell Factor C1 Complex Regulates Gluconeogenesis by Modulating PGC-1α Stability
  44. Diversity and specificity of the mitogen-activated protein kinase phosphatase-1 functions
  45. Erratum: Corrigendum: Peroxisome proliferation–associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity
  46. Peroxisome proliferation–associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity
  47. Loss of Mitogen-activated Protein Kinase Phosphatase-1 Protects from Hepatic Steatosis by Repression of Cell Death-inducing DNA Fragmentation Factor A (DFFA)-like Effector C (CIDEC)/Fat-specific Protein 27
  48. Mitogen-activated protein kinase phosphatase-1 – a potential therapeutic target in metabolic disease
  49. The MAP kinase phosphatase MKP-1 regulates BDNF-induced axon branching
  50. Analysis of Protein Tyrosine Phosphatases and Substrates
  51. MAP kinase phosphatase‐1 deficiency impairs skeletal muscle regeneration and exacerbates muscular dystrophy
  52. MAP kinase phosphatase-1 - a new player at the nexus between sarcopenia and metabolic disease
  53. MAPK phosphatase-1 facilitates the loss of oxidative myofibers associated with obesity in mice
  54. Physiological Signaling Specificity by Protein Tyrosine Phosphatases
  55. Role of MKP-1 in Osteoclasts and Bone Homeostasis
  56. JAK2 and SHP2 Reciprocally Regulate Tyrosine Phosphorylation and Stability of Proapoptotic Protein ASK1
  57. Noonan Syndrome-associated SHP-2/Ptpn11 Mutants Enhance SIRPα and PZR Tyrosyl Phosphorylation and Promote Adhesion-mediated ERK Activation
  58. A Novel Role of Vascular Endothelial Cadherin in Modulating c-Src Activation and Downstream Signaling of Vascular Endothelial Growth Factor
  59. c-Met Must Translocate to the Nucleus to Initiate Calcium Signals
  60. Nucleoplasmic Calcium Is Required for Cell Proliferation
  61. SHP-2 Regulates Cell Growth by Controlling the mTOR/S6 Kinase 1 Pathway
  62. Protein tyrosine phosphatase function: the substrate perspective
  63. Mitogen-activated protein kinase phosphatase-1 (MKP-1): a critical regulator of innate immune responses
  64. SHP-2 activates signaling of the nuclear factor of activated T cells to promote skeletal muscle growth
  65. Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity
  66. Calcium signaling in the nucleusThis paper is one of a selection of papers published in this Special Issue, entitled The Nucleus: A Cell Within A Cell.
  67. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses
  68. Gain-of-function/Noonan syndrome SHP-2/ Ptpn11 mutants enhance calcium oscillations and impair NFAT signaling
  69. Insulin Resistance in Heart and Liver Due to PPARα Overexpression
  70. The Noncatalytic Amino Terminus of Mitogen-Activated Protein Kinase Phosphatase 1 Directs Nuclear Targeting and Serum Response Element Transcriptional Regulation
  71. Essential Role for Mitogen-activated Protein (MAP) Kinase Phosphatase-1 in Stress-responsive MAP Kinase and Cell Survival Signaling
  72. Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus
  73. Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus
  74. SHP-2 Positively Regulates Myogenesis by Coupling to the Rho GTPase Signaling Pathway
  75. The Major Vault Protein Is a Novel Substrate for the Tyrosine Phosphatase SHP-2 and Scaffold Protein in Epidermal Growth Factor Signaling
  76. SHP-2 regulates the phosphatidylinositide 3?-kinase/Akt pathway and suppresses caspase 3-mediated apoptosis
  77. Nuclear and cytosolic calcium are regulated independently
  78. Epidermal Growth Factor-mediated Activation of the ETS Domain Transcription Factor Elk-1 Requires Nuclear Calcium
  79. Role of SHP-2 in Fibroblast Growth Factor Receptor-Mediated Suppression of Myogenesis in C2C12 Myoblasts
  80. Differential Role of β1Cand β1AIntegrin Cytoplasmic Variants in Modulating Focal Adhesion Kinase, Protein Kinase B/AKT, and Ras/Mitogen-activated Protein Kinase Pathways
  81. Epidermal Growth Factor Receptor and the Adaptor Protein p52Shc Are Specific Substrates of T-Cell Protein Tyrosine Phosphatase
  82. Regulation of Distinct Stages of Skeletal Muscle Differentiation by Mitogen-Activated Protein Kinases
  83. Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression.
  84. Different Signaling Roles of SHPTP2 in Insulin-induced GLUT1 Expression and GLUT4 Translocation
  85. Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras.
  86. Calcium as a permissive factor but not an initiation factor in DNA synthesis induction in cultured rat hepatocytes by the peroxisome proliferator ciprofibrate
  87. Alteration of rat liver endoplasmic reticulum Ca2+-ATPase thiol integrity by ciprofibrate, a peroxisome proliferator
  88. Reduction of rat liver endoplasmic reticulum Ca2+-ATPase activity and mobilization of hepatic intracellular calcium by ciprofibrate, a peroxisome proliferator